Skip to content
Brilliant Blue Biosciences logoBrilliant BlueBiosciences
Articles

Papers, explained in our own words

Every entry summarises what the study set out to test, what it found and why it changes how we design delivery systems. Browse research and reviews or search the collection.

706 articles

Showing 49–55 of 55 articles · Keyword: T cells Clear keyword

Nature Reviews Materials2017ReviewNon-viral Gene Delivery

49. Tools for translation: non-viral materials for therapeutic mRNA delivery

Khalid A. Hajj And Kathryn A. Whitehead

mRNA therapeutics have enormous potential for vaccines, cancer immunotherapy, protein replacement, and gene editing, but widespread clinical application is limited by the lack of safe and effective delivery vehicles. Naked mRNA is large (~10⁵–10⁶ Da), densely negatively charged, and rapidly degraded by nucleases; its…

Read the article
Nature2016ReviewNon-viral Gene Delivery

50. Mimicking biological functionality with polymers for biomedical applications

Green, J. J.; Elisseeff, J. H

Biomaterials must increasingly do more than simply avoid rejection; they must actively mimic biological structures and functions to direct cell behaviour, modulate immunity, and repair tissues. This review addresses how biologically inspired polymers can be designed for local tissue engineering, systemic therapeutic…

Read the article
2014ReviewNon-viral Gene Delivery

51. Nanocarrier-based immunotherapy in cancer management and research

Singh Ms, Bhaskar S.

Cancer immunotherapy can induce specific antitumor immunity, control metastases, and provide immunological memory, but faces barriers including immunosuppressive tumour microenvironments and poor delivery of immunomodulators. Nanocarriers offer a versatile way to deliver antigens, adjuvants, cytokines, antibodies…

Read the article
BioMed Research International.2014ReviewNon-viral Gene Delivery

52. Lipid Nanoparticles as Carriers for RNAi against Viral Infections Current Status and Future Perspectives

Torrecilla J, Rodríguez-Gascón A, Solinís Má, Del Pozo-Rodríguez A

Naked RNAi molecules are rapidly degraded by serum nucleases and cannot readily cross cell membranes because of their negative charge. Effective delivery systems are therefore required to exploit RNAi for antiviral therapy. Lipid nanoparticles (LNPs) are attractive because they are relatively safe, simple to produce…

Read the article
Current Opinion in Lipidology2012ReviewNon-viral Gene Delivery

53. Lipid-based carriers of microRNAs and intercellular communication

Vickers Kc, Remaley At

Extracellular miRNAs are unusually stable in plasma and their circulating levels change with disease, making them promising biomarkers. They are associated with lipid-based carriers—exosomes, microvesicles, apoptotic bodies, and lipoproteins—as well as lipid-free proteins. Whether these carriers mediate functional…

Read the article
Advanced Drug Delivery Reviews2005ReviewNon-viral Gene Delivery

54. PLGA microspheres for improved antigen delivery to dendritic cells as cellular vaccines

Ying Waeckerle-Men And Marcus Groettrup

Dendritic cell (DC)-based vaccines are limited by the short persistence of MHC class I/peptide complexes on the DC surface—often only a few hours—when soluble peptides are loaded exogenously. This short presentation limits CTL activation and vaccine efficacy. The authors investigated biodegradable PLGA microspheres…

Read the article
Trends in Immunology2002ReviewNon-viral Gene Delivery

55. Caveolae and Caveolin in Immune Cells: Distribution and Functions

James Harris, Dirk Werling, Jayne C. Hope, Geraldine Taylor, Chris J. Howard

Caveolae and caveolin are cholesterol-rich membrane microdomains involved in endocytosis, cholesterol regulation, and signal transduction, but their presence and function in immune cells have been contentious. This review addresses the need to clarify the distribution and roles of caveolae/caveolin in mammalian…

Read the article
Articles — page 3 | Brilliant Blue Biosciences